Quantitation of IgG kappa and IgG lambda in the cerebrospinal fluid by sandwich ELISA method

References

• Link, H.; Zettervall, O. Multiple Sclerosis: Disturbed Kappa: LambdaChain Ratio of Immunoglobulin G in Cerebrospinal Fluid. Clin. Exp. Immunol. 1970, 6, 435–438.
   PubMed Web of Science ®Google Scholar
• Zettervall, O.; Link, H. Electrophoretic Distribution of Kappa and Lambda Immunoglobulin Light Chain Determinants in Serum and Cerebrospinal Fluid in Multiple Sclerosis. Clin. Exp. Immunol. 1970, 7, 365–372.
   PubMed Web of Science ®Google Scholar
• Zeman, D.; Kušnierová, P.; Bartoš, V.; Hradílek, P.; Kurková, B.; Zapletalová, O. Quantitation of Free Light Chains in the Cerebrospinal Fluid Reliably Predicts Their Intrathecal Synthesis. Ann. Clin. Biochem. 2016, 53, 174–176.
   PubMed Web of Science ®Google Scholar
• Araga, S., Kagimoto, H., Wada, A.; Funamoto, K.; Inoue, K.; Takahashi, K. Kappa/Lambda Ratios in IgG, IgA and IgM of Cerebrospinal Fluid and of Sera in Patients with Multiple Sclerosis. Autoimmunity 1989, 5, 133–137.
   PubMed Web of Science ®Google Scholar
• Bradwell, A.R.; Harding, S.J.; Fourrier, N.J.; Wallis, G.L.F.; Drayson, M.T.; Carr-Smith, H.D.; Mead, G.P. Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios. Clin. Chem. 2009, 55, 1646–1655.
   PubMed Web of Science ®Google Scholar
• Zeman, D.; Hradílek, P.; Švagera, Z.; Mojžíšková, E.; Woznicová, I.; Zapletalová, O. Detection of Oligoclonal IgG Kappa and IgG Lambda Bands in Cerebrospinal Fluid and Serum with Hevylite™ Antibodies. Comparison with the Free Light Chain Oligoclonal Pattern. Fluids Barr. CNS 2012, 9, 5.
   PubMedGoogle Scholar
• Zeman, D.; Hradílek, P.; Kušnierová, P.; Píža, R.; Reguliová, K.; Woznicová, I.; Zapletalová, O. Oligoclonal Free Light Chains in Cerebrospinal Fluid as Markers of Intrathecal Inflammation. Comparison with Oligoclonal IgG. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2015, 159, 104–113.
   PubMed Web of Science ®Google Scholar
• Teunissen, C.; Menge, T.; Altintas, A.; Álvarez-Cermeño, J.C.; Bertolotto, A.; Berven, F. S.; Brundin, L.; Comabella, M.; Degn, M.; Deisenhammer, F.; Fazekas, F.; Franciotta, D.; Frederiksen, J.L.; Galimberti, D.; Gnanapavan, S.; Hegen, H.; Hemmer, B.; Hintzen, R.; Hughes, S.; Iacobaeus, E.; Kroksveen, A.C.; Kuhle, J.; Richert, J.; Tumani, H.; Villar, L.M.; Drulovic, J.; Dumjovic, I.; Khalil, M.; Bartos, A. Consensus Definitions and Application Guidelines for Control Groups in Cerebrospinal Fluid Biomarker Studies in Multiple sclerosis. Mult. Scler. 2013, 19, 1802–1809.
   PubMed Web of Science ®Google Scholar
• Kušnierová, P.; Zeman, D.; Šigutová, R.; Ploticová, V.; Všianský, F.; Švagera, Z. Contribution of Hevylite Assays by Patients with Monoclonal Gammopathy. Chem. Listy 2013, 107, s393–s395.
   Web of Science ®Google Scholar
• The Binding Site Ltd. Hevylite Reference Intervals. In The Binding Site Group, Ltd. (Ed.), Serum Free Light Chain Analysis plus Hevylite. 7th ed.; The Binding Site Group, Ltd., Birmingham, UK, 2015; pp. 105–109.
   Google Scholar
• Bojková, J. Detection of Low Concentrations of Paraprotein in Serum and Urine by Isoelectric Focusing with Affinity Immunoblotting. Master’s thesis. St. Elizabeth University College of Health and Social Work Bratislava, Institute for Healthcare Disciplines, Bratislava, 2015.
   Google Scholar
• Reiber, H. Flow Rate of Cerebrospinal Fluid (CSF) – A Concept Common to Normal Blood-CSF Barrier Function and to Dysfunction in Neurological Diseases. J. Neurol. Sci. 1994, 122, 189–203.
   PubMed Web of Science ®Google Scholar
• Reiber, H. Immunglobuline. In Neurologische Labordiagnostik; Wildemann, B.; Oschmann, P.; Reiber, H. Eds.; Thieme: Stuttgart, 2006; p. 47.
   Google Scholar
• Link, H.; Müller, R. Immunoglobulins in Multiple Sclerosis and Infections of the Nervous System. Arch. Neurol. 1971, 25, 326–344.
   PubMedGoogle Scholar
• Roberts-Thomson, P.J.; Esiri, M.M.; Young, A.C.; Maclennan, I.C.M. Cerebrospinal Fluid Immunoglobulin Quotients, Kappa/Lambda Ratios, and Viral Antibody Titres in Neurological Disease. J. Clin. Path. 1976, 29, 1105–1115.
   PubMed Web of Science ®Google Scholar
• Bollengier, F.; Rabinovitch, N.; Lowenthal, A. Oligoclonal Immunoglobulins, Light Chain Ratios and Free Light Chains in Cerebrospinal Fluid and Serum from Patients Affected with Various Neurological Diseases. J. Clin. Chem. Clin. Biochem. 1978, 16, 165–173.
   PubMedGoogle Scholar
• Eickhoff, K.; Heipertz, R., Wikström, J. Determination of k/l Immunoglobulin Light Chain Ratios in CSF from Patients with Multiple Sclerosis and Other Neurological Diseases. Acta Neurol. Scand. 1978, 57, 385–395.
   PubMed Web of Science ®Google Scholar
• Link, H.; Laurenzi, M.A. Immunoglobulin Class and Light Chain Type of Oligoclonal Bands in CSF in Multiple Sclerosis Determined by Agarose Gel Electrophoresis and Immunofixation. Ann. Neurol. 1979, 6, 107–110.
   PubMed Web of Science ®Google Scholar
• Jenkins, M.A.; Cheng, L.; Ratnaike, S. Multiple Sclerosis: Use of Light-chain Typing to Assist Diagnosis. Ann. Clin. Biochem. 2001, 38, 235–241.
   PubMed Web of Science ®Google Scholar
• Nováčková, L.; Zeman, D. Detection of Oligoclonal IgG Bands in Cerebrospinal Fluid and Serum: Comparison between Commercially Available Immunofixation Method and Home-made Affinity Immunoblotting Method and Evaluation of Interobserver Agreement. Klin. Biochem. Metab. 2011, 19, 229–233.
   Google Scholar
• Petzold, A. Intrathecal Oligoclonal IgG Synthesis in Multiple Sclerosis. J. Neuroimmunol. 2013, 262, 1–10.
   PubMed Web of Science ®Google Scholar